checkAd
Innovation Pharmaceuticals Aktie
ISIN: US45782D1000 · WKN: A2DTBJ · SYM: IPIX
0,021
 
USD
+0,48 %
+0,000 USD
Letzter Kurs 26.01.23 · Nasdaq OTC

Neueste Nachrichten

New In Vitro Data Supporting the Broad-Spectrum Antiviral Activity of Innovation Pharmaceuticals' Brilacidin Presented at 2022 Military Health System Research Symposium
15.09.22 · Accesswire · Innovation Pharmaceuticals
Innovation Pharmaceuticals' Investment in BT BeaMedical Helping Advance New Surgical Laser Platform
13.09.22 · Accesswire · Innovation Pharmaceuticals
Innovation Pharmaceuticals Announces NIH/NIAID-Affiliated Researchers to Evaluate Brilacidin's Treatment Potential Against Monkeypox
05.08.22 · Accesswire · Innovation Pharmaceuticals
Provider and Payer Analysis Supports Potential Commercialization of Innovation Pharmaceutical's Brilacidin as a Novel Oral Mucositis Drug Candidate
22.07.22 · Accesswire · Innovation Pharmaceuticals
Innovation Pharmaceuticals Announces New Antiviral Research on Brilacidin in Bunyaviruses and Alphaviruses to be Presented at the 2022 Military Health System Research Symposium
28.06.22 · Accesswire · Innovation Pharmaceuticals
Innovation Pharmaceuticals Reports Brilacidin Inhibits Omicron, Delta, Gamma and Alpha SARS-CoV-2 Variants Based on In Vitro Testing by NIH/NIAID-Sponsored and Rutgers University Researchers
23.06.22 · Accesswire · Innovation Pharmaceuticals
Innovation Pharmaceuticals Acquires Stake in Squalus Medical, Seeks to Reshape Cancer and Epilepsy Treatments Through a New Image Guided Laser-Based Ablation Technology
15.06.22 · Accesswire · Innovation Pharmaceuticals